A Imprisonment of 2 years and 6 months, Defendant B and C shall be punished by a fine of 2,00,000 won, and Defendant D Co., Ltd. shall be punished by a fine of 20,000.

Defendant

A is a representative director of the mutual pharmaceutical company called Ansan-si MD Co., Ltd., and Defendant B is the chairperson of the above company, who is registered as a manufacturing supervisor in the Ministry of Food and Drug Safety, Defendant C is the managing director of the above company, and Defendant C is a person registered as a manufacturing supervisor in the Ministry of Food and Drug Safety, and Defendant D (Representative A) is a corporation established for the purpose of manufacturing and selling medicine.

1. Defendant A

A. The Defendant, as the representative of the D Co., Ltd., who obtained marketing approval of drugs, failed to sell or store or display drugs containing false or misleading information regarding the relevant drugs on containers or packages, or the period of use dangerous to health and sanitation, etc. for the purpose of sale. However, despite the fact that the distribution period is imminent, or that the drugs, the distribution period of which has already expired, are difficult to be sold as the drugs, or returned from a pharmacy or wholesaler, and returned the drugs to a new container for which the distribution period has already expired, and then, sent the said drugs to the new container, and sold them by means of new entry of the manufacturing number